Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) Institutional Ownership: 19.10% (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688488 Jiangsu Aidea Pharmaceutical Group Co Ltd SHSE:688488
70 GF Score
Price ¥18.15
GF Value ¥25.35
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Jiangsu Aidea Pharmaceutical Group Co Institutional Ownership?

Jiangsu Aidea Pharmaceutical Group Co SHSE:688488 +5.71% 70 Institutional Ownership is 19.10% as of Aug. 15, 2026. GuruFocus rates SHSE:688488 with a GF Score™ of 70/100 and a GF Value™ of ¥25.35 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Jiangsu Aidea Pharmaceutical Group Co's institutional ownership is 19.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Jiangsu Aidea Pharmaceutical Group Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Jiangsu Aidea Pharmaceutical Group Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Jiangsu Aidea Pharmaceutical Group Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Jiangsu Aidea Pharmaceutical Group Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Aidea Pharmaceutical Group Co Institutional Ownership Chart

Jiangsu Aidea Pharmaceutical Group Co Historical Data

The historical data trend for Jiangsu Aidea Pharmaceutical Group Co can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 12.61 12.60 12.60 19.10 19.10 19.10 19.10 19.10 19.10 19.10
SHSE:688488
70GF Score
Jiangsu Aidea Pharmaceutical Group Co Ltd SHSE:688488
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Aidea Pharmaceutical Group Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 19.10% mean?
Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) has a Institutional Ownership of 19.10% as of Aug. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Jiangsu Aidea Pharmaceutical Group Co and its competitors.
Is Jiangsu Aidea Pharmaceutical Group Co's Institutional Ownership too high?
Jiangsu Aidea Pharmaceutical Group Co's current Institutional Ownership is 19.10%. Overall, Jiangsu Aidea Pharmaceutical Group Co has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Aidea Pharmaceutical Group Co's Institutional Ownership compare to VRTX and REGN?
Jiangsu Aidea Pharmaceutical Group Co's Institutional Ownership of 19.10% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Jiangsu Aidea Pharmaceutical Group Co and its competitors. Jiangsu Aidea Pharmaceutical Group Co's current Institutional Ownership is 19.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Aidea Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥25.35, compared to a current price of ¥18.15 — trading 28.4% below its estimated fair value. The current Institutional Ownership is 19.10%. Jiangsu Aidea Pharmaceutical Group Co's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488), the current Institutional Ownership is 19.10% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Aidea Pharmaceutical Group Co (SHSE:688488) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Aidea Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥18.15 is trading 28.4% below its estimated GF Value™ of ¥25.35. GuruFocus considers Jiangsu Aidea Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:688488:

  • Institutional Ownership: 19.10%
  • GF Value™: ¥25.35 vs. price of ¥18.15 (28.4% below fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Aidea Pharmaceutical Group Co Business Description

Address No. 69, Xin Ganquan West Road, Hanjiang District, Jiangsu Province, Yangzhou, CHN, 225008
Jiangsu Aidea Pharmaceutical Group Co Ltd is engaged in the production and sales of human protein products, and also carries out some generic drug business and distributes Abbott's HIV diagnostic equipment and reagents.
70GF Score

Get the complete analysis for SHSE:688488

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.15
Price
¥25.35
GF Value